0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Heart Failure Therapeutics - Global Market Insights and Sales Trends 2024
Published Date: December 2023
|
Report Code: QYRE-Auto-21R13862
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Heart Failure Therapeutics Market Research Report 2023
BUY CHAPTERS

Heart Failure Therapeutics - Global Market Insights and Sales Trends 2024

Code: QYRE-Auto-21R13862
Report
December 2023
Pages:113
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Heart Failure Therapeutics - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Heart Failure Therapeutics -  Market

Heart Failure Therapeutics - Market

Heart failure (HF), often referred to as congestive heart failure (CHF), is when the heart is unable to pump sufficiently to maintain blood flow to meet the body's needs. Signs and symptoms commonly include shortness of breath, excessive tiredness, and leg swelling.The shortness of breath is usually worse with exercise, while lying down, and may wake the person at night.A limited ability to exercise is also a common feature. Chest pain, including angina, does not typically occur due to heart failure.
The global Heart Failure Therapeutics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Heart Failure Therapeutics in various end use industries. The expanding demands from the Hospital, Clinic and Medical Research Organization,, are propelling Heart Failure Therapeutics market. Diagnosis, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Prognosis segment is estimated at % CAGR for the next seven-year period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Heart Failure Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Heart Failure Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Heart Failure Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Heart Failure Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Heart Failure Therapeutics covered in this report include Bayer, Cynokinetics, Les Laboratoires Servier, Merck & Co., Novartis, Procoralan, Bristol-Myers Squibb Company, Cardiorentis AG and CVie Therapeutics Limited, etc.
The global Heart Failure Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bayer
Cynokinetics
Les Laboratoires Servier
Merck & Co.
Novartis
Procoralan
Bristol-Myers Squibb Company
Cardiorentis AG
CVie Therapeutics Limited
Orion Corporation
PhaseBio Pharmaceuticals

Scope of Heart Failure Therapeutics - Market Report

Report Metric Details
Report Name Heart Failure Therapeutics - Market
CAGR 5%
Market Segment by Product Type
  • B-Blockers
  • Calcium Channel Blockers
  • Cardiac Glycosides
  • Diuretics
  • Morphine
  • Vasodilators/Nitrates
Global Heart Failure Therapeutics market, by region:
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Heart Failure Therapeutics market, Segment by Type:
  • Diagnosis
  • Prognosis
  • Treatment Options and Treatment Algorithm
Global Heart Failure Therapeutics market, by Application
  • Hospital
  • Clinic
  • Medical Research Organization
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter Four: Detailed analysis of Heart Failure Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
  • Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
  • Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter Twelve: Research Finding/Conclusion

FAQ for this report

What are the Application segmentation covered in the Heart Failure Therapeutics - Market report?

Ans: The Applications covered in the Heart Failure Therapeutics - Market report are Hospital, Clinic, Medical Research Organization

What are the Type segmentation covered in the Heart Failure Therapeutics - Market report?

Ans: The Types covered in the Heart Failure Therapeutics - Market report are Diagnosis, Prognosis, Treatment Options and Treatment Algorithm

1 Market Overview of Heart Failure Therapeutics
1.1 Heart Failure Therapeutics Market Overview
1.1.1 Heart Failure Therapeutics Product Scope
1.1.2 Heart Failure Therapeutics Market Status and Outlook
1.2 Global Heart Failure Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Heart Failure Therapeutics Market Size by Region (2018-2029)
1.4 Global Heart Failure Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global Heart Failure Therapeutics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Heart Failure Therapeutics Market Size (2018-2029)
1.6.1 North America Heart Failure Therapeutics Market Size (2018-2029)
1.6.2 Europe Heart Failure Therapeutics Market Size (2018-2029)
1.6.3 Asia-Pacific Heart Failure Therapeutics Market Size (2018-2029)
1.6.4 Latin America Heart Failure Therapeutics Market Size (2018-2029)
1.6.5 Middle East & Africa Heart Failure Therapeutics Market Size (2018-2029)
2 Heart Failure Therapeutics Market by Type
2.1 Introduction
2.1.1 Diagnosis
2.1.2 Prognosis
2.1.3 Treatment Options and Treatment Algorithm
2.2 Global Heart Failure Therapeutics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Heart Failure Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global Heart Failure Therapeutics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Heart Failure Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Heart Failure Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Heart Failure Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Heart Failure Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Heart Failure Therapeutics Revenue Breakdown by Type (2018-2029)
3 Heart Failure Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Medical Research Organization
3.2 Global Heart Failure Therapeutics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Heart Failure Therapeutics Historic Market Size by Application (2018-2023)
3.2.2 Global Heart Failure Therapeutics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Heart Failure Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Heart Failure Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Heart Failure Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Heart Failure Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Heart Failure Therapeutics Revenue Breakdown by Application (2018-2029)
4 Heart Failure Therapeutics Competition Analysis by Players
4.1 Global Heart Failure Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Heart Failure Therapeutics as of 2022)
4.3 Date of Key Players Enter into Heart Failure Therapeutics Market
4.4 Global Top Players Heart Failure Therapeutics Headquarters and Area Served
4.5 Key Players Heart Failure Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Heart Failure Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Bayer
5.1.1 Bayer Profile
5.1.2 Bayer Main Business
5.1.3 Bayer Heart Failure Therapeutics Products, Services and Solutions
5.1.4 Bayer Heart Failure Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 Bayer Recent Developments
5.2 Cynokinetics
5.2.1 Cynokinetics Profile
5.2.2 Cynokinetics Main Business
5.2.3 Cynokinetics Heart Failure Therapeutics Products, Services and Solutions
5.2.4 Cynokinetics Heart Failure Therapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 Cynokinetics Recent Developments
5.3 Les Laboratoires Servier
5.3.1 Les Laboratoires Servier Profile
5.3.2 Les Laboratoires Servier Main Business
5.3.3 Les Laboratoires Servier Heart Failure Therapeutics Products, Services and Solutions
5.3.4 Les Laboratoires Servier Heart Failure Therapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 Merck & Co. Recent Developments
5.4 Merck & Co.
5.4.1 Merck & Co. Profile
5.4.2 Merck & Co. Main Business
5.4.3 Merck & Co. Heart Failure Therapeutics Products, Services and Solutions
5.4.4 Merck & Co. Heart Failure Therapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 Merck & Co. Recent Developments
5.5 Novartis
5.5.1 Novartis Profile
5.5.2 Novartis Main Business
5.5.3 Novartis Heart Failure Therapeutics Products, Services and Solutions
5.5.4 Novartis Heart Failure Therapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 Novartis Recent Developments
5.6 Procoralan
5.6.1 Procoralan Profile
5.6.2 Procoralan Main Business
5.6.3 Procoralan Heart Failure Therapeutics Products, Services and Solutions
5.6.4 Procoralan Heart Failure Therapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 Procoralan Recent Developments
5.7 Bristol-Myers Squibb Company
5.7.1 Bristol-Myers Squibb Company Profile
5.7.2 Bristol-Myers Squibb Company Main Business
5.7.3 Bristol-Myers Squibb Company Heart Failure Therapeutics Products, Services and Solutions
5.7.4 Bristol-Myers Squibb Company Heart Failure Therapeutics Revenue (US$ Million) & (2018-2023)
5.7.5 Bristol-Myers Squibb Company Recent Developments
5.8 Cardiorentis AG
5.8.1 Cardiorentis AG Profile
5.8.2 Cardiorentis AG Main Business
5.8.3 Cardiorentis AG Heart Failure Therapeutics Products, Services and Solutions
5.8.4 Cardiorentis AG Heart Failure Therapeutics Revenue (US$ Million) & (2018-2023)
5.8.5 Cardiorentis AG Recent Developments
5.9 CVie Therapeutics Limited
5.9.1 CVie Therapeutics Limited Profile
5.9.2 CVie Therapeutics Limited Main Business
5.9.3 CVie Therapeutics Limited Heart Failure Therapeutics Products, Services and Solutions
5.9.4 CVie Therapeutics Limited Heart Failure Therapeutics Revenue (US$ Million) & (2018-2023)
5.9.5 CVie Therapeutics Limited Recent Developments
5.10 Orion Corporation
5.10.1 Orion Corporation Profile
5.10.2 Orion Corporation Main Business
5.10.3 Orion Corporation Heart Failure Therapeutics Products, Services and Solutions
5.10.4 Orion Corporation Heart Failure Therapeutics Revenue (US$ Million) & (2018-2023)
5.10.5 Orion Corporation Recent Developments
5.11 PhaseBio Pharmaceuticals
5.11.1 PhaseBio Pharmaceuticals Profile
5.11.2 PhaseBio Pharmaceuticals Main Business
5.11.3 PhaseBio Pharmaceuticals Heart Failure Therapeutics Products, Services and Solutions
5.11.4 PhaseBio Pharmaceuticals Heart Failure Therapeutics Revenue (US$ Million) & (2018-2023)
5.11.5 PhaseBio Pharmaceuticals Recent Developments
5.12 Market Segment by Product Type
5.12.1 Market Segment by Product Type Profile
5.12.2 Market Segment by Product Type Main Business
5.12.3 Market Segment by Product Type Heart Failure Therapeutics Products, Services and Solutions
5.12.4 Market Segment by Product Type Heart Failure Therapeutics Revenue (US$ Million) & (2018-2023)
5.12.5 Market Segment by Product Type Recent Developments
5.13 B-Blockers
5.13.1 B-Blockers Profile
5.13.2 B-Blockers Main Business
5.13.3 B-Blockers Heart Failure Therapeutics Products, Services and Solutions
5.13.4 B-Blockers Heart Failure Therapeutics Revenue (US$ Million) & (2018-2023)
5.13.5 B-Blockers Recent Developments
5.14 Calcium Channel Blockers
5.14.1 Calcium Channel Blockers Profile
5.14.2 Calcium Channel Blockers Main Business
5.14.3 Calcium Channel Blockers Heart Failure Therapeutics Products, Services and Solutions
5.14.4 Calcium Channel Blockers Heart Failure Therapeutics Revenue (US$ Million) & (2018-2023)
5.14.5 Calcium Channel Blockers Recent Developments
5.15 Cardiac Glycosides
5.15.1 Cardiac Glycosides Profile
5.15.2 Cardiac Glycosides Main Business
5.15.3 Cardiac Glycosides Heart Failure Therapeutics Products, Services and Solutions
5.15.4 Cardiac Glycosides Heart Failure Therapeutics Revenue (US$ Million) & (2018-2023)
5.15.5 Cardiac Glycosides Recent Developments
5.16 Diuretics
5.16.1 Diuretics Profile
5.16.2 Diuretics Main Business
5.16.3 Diuretics Heart Failure Therapeutics Products, Services and Solutions
5.16.4 Diuretics Heart Failure Therapeutics Revenue (US$ Million) & (2018-2023)
5.16.5 Diuretics Recent Developments
5.17 Morphine
5.17.1 Morphine Profile
5.17.2 Morphine Main Business
5.17.3 Morphine Heart Failure Therapeutics Products, Services and Solutions
5.17.4 Morphine Heart Failure Therapeutics Revenue (US$ Million) & (2018-2023)
5.17.5 Morphine Recent Developments
5.18 Vasodilators/Nitrates
5.18.1 Vasodilators/Nitrates Profile
5.18.2 Vasodilators/Nitrates Main Business
5.18.3 Vasodilators/Nitrates Heart Failure Therapeutics Products, Services and Solutions
5.18.4 Vasodilators/Nitrates Heart Failure Therapeutics Revenue (US$ Million) & (2018-2023)
5.18.5 Vasodilators/Nitrates Recent Developments
6 North America
6.1 North America Heart Failure Therapeutics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Heart Failure Therapeutics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Heart Failure Therapeutics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Heart Failure Therapeutics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Heart Failure Therapeutics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Heart Failure Therapeutics Market Dynamics
11.1 Heart Failure Therapeutics Industry Trends
11.2 Heart Failure Therapeutics Market Drivers
11.3 Heart Failure Therapeutics Market Challenges
11.4 Heart Failure Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables
    Table 1. Global Market Heart Failure Therapeutics Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
    Table 2. Global Heart Failure Therapeutics Market Size by Region (2018-2023) & (US$ Million)
    Table 3. Global Heart Failure Therapeutics Market Size Share by Region (2018-2023)
    Table 4. Global Heart Failure Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 5. Global Heart Failure Therapeutics Forecasted Market Size Share by Region (2024-2029)
    Table 6. Global Heart Failure Therapeutics Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
    Table 7. Global Heart Failure Therapeutics Market Size by Type (2018-2023) & (US$ Million)
    Table 8. Global Heart Failure Therapeutics Revenue Market Share by Type (2018-2023)
    Table 9. Global Heart Failure Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 10. Global Heart Failure Therapeutics Revenue Market Share by Type (2024-2029)
    Table 11. North America Heart Failure Therapeutics Revenue by Type (2018-2023) & (US$ Million)
    Table 12. North America Heart Failure Therapeutics Revenue by Type (2024-2029) & (US$ Million)
    Table 13. Europe Heart Failure Therapeutics Revenue by Type (2018-2023) & (US$ Million)
    Table 14. Europe Heart Failure Therapeutics Revenue by Type (2024-2029) & (US$ Million)
    Table 15. Asia-Pacific Heart Failure Therapeutics Revenue by Type (2018-2023) & (US$ Million)
    Table 16. Asia-Pacific Heart Failure Therapeutics Revenue by Type (2024-2029) & (US$ Million)
    Table 17. Latin America Heart Failure Therapeutics Revenue by Type (2018-2023) & (US$ Million)
    Table 18. Latin America Heart Failure Therapeutics Revenue by Type (2024-2029) & (US$ Million)
    Table 19. Middle East and Africa Heart Failure Therapeutics Revenue by Type (2018-2023) & (US$ Million)
    Table 20. Middle East and Africa Heart Failure Therapeutics Revenue by Type (2024-2029) & (US$ Million)
    Table 21. Global Heart Failure Therapeutics Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
    Table 22. Global Heart Failure Therapeutics Market Size by Application (2018-2023) & (US$ Million)
    Table 23. Global Heart Failure Therapeutics Revenue Market Share by Application (2018-2023)
    Table 24. Global Heart Failure Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 25. Global Heart Failure Therapeutics Revenue Market Share by Application (2024-2029)
    Table 26. North America Heart Failure Therapeutics Revenue by Application (2018-2023) & (US$ Million)
    Table 27. North America Heart Failure Therapeutics Revenue by Application (2024-2029) & (US$ Million)
    Table 28. Europe Heart Failure Therapeutics Revenue by Application (2018-2023) & (US$ Million)
    Table 29. Europe Heart Failure Therapeutics Revenue by Application (2024-2029) & (US$ Million)
    Table 30. Asia-Pacific Heart Failure Therapeutics Revenue by Application (2018-2023) & (US$ Million)
    Table 31. Asia-Pacific Heart Failure Therapeutics Revenue by Application (2024-2029) & (US$ Million)
    Table 32. Latin America Heart Failure Therapeutics Revenue by Application (2018-2023) & (US$ Million)
    Table 33. Latin America Heart Failure Therapeutics Revenue by Application (2024-2029) & (US$ Million)
    Table 34. Middle East and Africa Heart Failure Therapeutics Revenue by Application (2018-2023) & (US$ Million)
    Table 35. Middle East and Africa Heart Failure Therapeutics Revenue by Application (2024-2029) & (US$ Million)
    Table 36. Global Heart Failure Therapeutics Revenue (US$ Million) by Players (2018-2023)
    Table 37. Global Heart Failure Therapeutics Revenue Market Share by Players (2018-2023)
    Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Heart Failure Therapeutics as of 2022)
    Table 39. Date of Key Players Enter into Heart Failure Therapeutics Market
    Table 40. Global Heart Failure Therapeutics Key Players Headquarters and Area Served
    Table 41. Heart Failure Therapeutics Product Solution and Service
    Table 42. Global Heart Failure Therapeutics Players Market Concentration Ratio (CR5 and HHI)
    Table 43. Mergers & Acquisitions, Expansion Plans
    Table 44. Bayer Basic Information List
    Table 45. Bayer Description and Business Overview
    Table 46. Bayer Heart Failure Therapeutics Products, Services and Solutions
    Table 47. Revenue (US$ Million) in Heart Failure Therapeutics Business of Bayer (2018-2023)
    Table 48. Bayer Recent Developments
    Table 49. Cynokinetics Basic Information List
    Table 50. Cynokinetics Description and Business Overview
    Table 51. Cynokinetics Heart Failure Therapeutics Products, Services and Solutions
    Table 52. Revenue (US$ Million) in Heart Failure Therapeutics Business of Cynokinetics (2018-2023)
    Table 53. Cynokinetics Recent Developments
    Table 54. Les Laboratoires Servier Basic Information List
    Table 55. Les Laboratoires Servier Description and Business Overview
    Table 56. Les Laboratoires Servier Heart Failure Therapeutics Products, Services and Solutions
    Table 57. Revenue (US$ Million) in Heart Failure Therapeutics Business of Les Laboratoires Servier (2018-2023)
    Table 58. Les Laboratoires Servier Recent Developments
    Table 59. Merck & Co. Basic Information List
    Table 60. Merck & Co. Description and Business Overview
    Table 61. Merck & Co. Heart Failure Therapeutics Products, Services and Solutions
    Table 62. Revenue (US$ Million) in Heart Failure Therapeutics Business of Merck & Co. (2018-2023)
    Table 63. Merck & Co. Recent Developments
    Table 64. Novartis Basic Information List
    Table 65. Novartis Description and Business Overview
    Table 66. Novartis Heart Failure Therapeutics Products, Services and Solutions
    Table 67. Revenue (US$ Million) in Heart Failure Therapeutics Business of Novartis (2018-2023)
    Table 68. Novartis Recent Developments
    Table 69. Procoralan Basic Information List
    Table 70. Procoralan Description and Business Overview
    Table 71. Procoralan Heart Failure Therapeutics Products, Services and Solutions
    Table 72. Revenue (US$ Million) in Heart Failure Therapeutics Business of Procoralan (2018-2023)
    Table 73. Procoralan Recent Developments
    Table 74. Bristol-Myers Squibb Company Basic Information List
    Table 75. Bristol-Myers Squibb Company Description and Business Overview
    Table 76. Bristol-Myers Squibb Company Heart Failure Therapeutics Products, Services and Solutions
    Table 77. Revenue (US$ Million) in Heart Failure Therapeutics Business of Bristol-Myers Squibb Company (2018-2023)
    Table 78. Bristol-Myers Squibb Company Recent Developments
    Table 79. Cardiorentis AG Basic Information List
    Table 80. Cardiorentis AG Description and Business Overview
    Table 81. Cardiorentis AG Heart Failure Therapeutics Products, Services and Solutions
    Table 82. Revenue (US$ Million) in Heart Failure Therapeutics Business of Cardiorentis AG (2018-2023)
    Table 83. Cardiorentis AG Recent Developments
    Table 84. CVie Therapeutics Limited Basic Information List
    Table 85. CVie Therapeutics Limited Description and Business Overview
    Table 86. CVie Therapeutics Limited Heart Failure Therapeutics Products, Services and Solutions
    Table 87. Revenue (US$ Million) in Heart Failure Therapeutics Business of CVie Therapeutics Limited (2018-2023)
    Table 88. CVie Therapeutics Limited Recent Developments
    Table 89. Orion Corporation Basic Information List
    Table 90. Orion Corporation Description and Business Overview
    Table 91. Orion Corporation Heart Failure Therapeutics Products, Services and Solutions
    Table 92. Revenue (US$ Million) in Heart Failure Therapeutics Business of Orion Corporation (2018-2023)
    Table 93. Orion Corporation Recent Developments
    Table 94. PhaseBio Pharmaceuticals Basic Information List
    Table 95. PhaseBio Pharmaceuticals Description and Business Overview
    Table 96. PhaseBio Pharmaceuticals Heart Failure Therapeutics Products, Services and Solutions
    Table 97. Revenue (US$ Million) in Heart Failure Therapeutics Business of PhaseBio Pharmaceuticals (2018-2023)
    Table 98. PhaseBio Pharmaceuticals Recent Developments
    Table 99. Market Segment by Product Type Basic Information List
    Table 100. Market Segment by Product Type Description and Business Overview
    Table 101. Market Segment by Product Type Heart Failure Therapeutics Products, Services and Solutions
    Table 102. Revenue (US$ Million) in Heart Failure Therapeutics Business of Market Segment by Product Type (2018-2023)
    Table 103. Market Segment by Product Type Recent Developments
    Table 104. B-Blockers Basic Information List
    Table 105. B-Blockers Description and Business Overview
    Table 106. B-Blockers Heart Failure Therapeutics Products, Services and Solutions
    Table 107. Revenue (US$ Million) in Heart Failure Therapeutics Business of B-Blockers (2018-2023)
    Table 108. B-Blockers Recent Developments
    Table 109. Calcium Channel Blockers Basic Information List
    Table 110. Calcium Channel Blockers Description and Business Overview
    Table 111. Calcium Channel Blockers Heart Failure Therapeutics Products, Services and Solutions
    Table 112. Revenue (US$ Million) in Heart Failure Therapeutics Business of Calcium Channel Blockers (2018-2023)
    Table 113. Calcium Channel Blockers Recent Developments
    Table 114. Cardiac Glycosides Basic Information List
    Table 115. Cardiac Glycosides Description and Business Overview
    Table 116. Cardiac Glycosides Heart Failure Therapeutics Products, Services and Solutions
    Table 117. Revenue (US$ Million) in Heart Failure Therapeutics Business of Cardiac Glycosides (2018-2023)
    Table 118. Cardiac Glycosides Recent Developments
    Table 119. Diuretics Basic Information List
    Table 120. Diuretics Description and Business Overview
    Table 121. Diuretics Heart Failure Therapeutics Products, Services and Solutions
    Table 122. Revenue (US$ Million) in Heart Failure Therapeutics Business of Diuretics (2018-2023)
    Table 123. Diuretics Recent Developments
    Table 124. Morphine Basic Information List
    Table 125. Morphine Description and Business Overview
    Table 126. Morphine Heart Failure Therapeutics Products, Services and Solutions
    Table 127. Revenue (US$ Million) in Heart Failure Therapeutics Business of Morphine (2018-2023)
    Table 128. Morphine Recent Developments
    Table 129. Vasodilators/Nitrates Basic Information List
    Table 130. Vasodilators/Nitrates Description and Business Overview
    Table 131. Vasodilators/Nitrates Heart Failure Therapeutics Products, Services and Solutions
    Table 132. Revenue (US$ Million) in Heart Failure Therapeutics Business of Vasodilators/Nitrates (2018-2023)
    Table 133. Vasodilators/Nitrates Recent Developments
    Table 134. North America Heart Failure Therapeutics Market Size by Country (2018-2023) & (US$ Million)
    Table 135. North America Heart Failure Therapeutics Market Size by Country (2024-2029) & (US$ Million)
    Table 136. Europe Heart Failure Therapeutics Market Size by Country (2018-2023) & (US$ Million)
    Table 137. Europe Heart Failure Therapeutics Market Size by Country (2024-2029) & (US$ Million)
    Table 138. Asia-Pacific Heart Failure Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 139. Asia-Pacific Heart Failure Therapeutics Market Size by Region (2018-2023) & (US$ Million)
    Table 140. Asia-Pacific Heart Failure Therapeutics Market Size by Region (2024-2029) & (US$ Million)
    Table 141. Asia-Pacific Heart Failure Therapeutics Market Share by Region (2018-2023)
    Table 142. Asia-Pacific Heart Failure Therapeutics Market Share by Region (2024-2029)
    Table 143. Latin America Heart Failure Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 144. Latin America Heart Failure Therapeutics Market Size by Country (2018-2023) & (US$ Million)
    Table 145. Latin America Heart Failure Therapeutics Market Size by Country (2024-2029) & (US$ Million)
    Table 146. Middle East & Africa Heart Failure Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 147. Middle East & Africa Heart Failure Therapeutics Market Size by Country (2018-2023) & (US$ Million)
    Table 148. Middle East & Africa Heart Failure Therapeutics Market Size by Country (2024-2029) & (US$ Million)
    Table 149. Heart Failure Therapeutics Market Trends
    Table 150. Heart Failure Therapeutics Market Drivers
    Table 151. Heart Failure Therapeutics Market Challenges
    Table 152. Heart Failure Therapeutics Market Restraints
    Table 153. Research Programs/Design for This Report
    Table 154. Key Data Information from Secondary Sources
    Table 155. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Heart Failure Therapeutics Market Size Year-over-Year 2018-2029 & (US$ Million)
    Figure 2. Global Heart Failure Therapeutics Market Size (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Heart Failure Therapeutics Market Share by Regions: 2022 VS 2029
    Figure 4. Global Heart Failure Therapeutics Forecasted Market Size Share by Region (2024-2029)
    Figure 5. North America Heart Failure Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 6. Europe Heart Failure Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 7. Asia-Pacific Heart Failure Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 8. Latin America Heart Failure Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 9. Middle East & Africa Heart Failure Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 10. Product Picture of Diagnosis
    Figure 11. Global Diagnosis Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 12. Product Picture of Prognosis
    Figure 13. Global Prognosis Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 14. Product Picture of Treatment Options and Treatment Algorithm
    Figure 15. Global Treatment Options and Treatment Algorithm Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 16. Global Heart Failure Therapeutics Market Size Share by Type: 2022 & 2029
    Figure 17. North America Heart Failure Therapeutics Revenue Market Share by Type (2018-2029)
    Figure 18. Europe Heart Failure Therapeutics Revenue Market Share by Type (2018-2029)
    Figure 19. Asia-Pacific Heart Failure Therapeutics Revenue Market Share by Type (2018-2029)
    Figure 20. Latin America Heart Failure Therapeutics Revenue Market Share by Type (2018-2029)
    Figure 21. Middle East and Africa Heart Failure Therapeutics Revenue Market Share by Type (2018-2029)
    Figure 22. Hospital Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 23. Clinic Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 24. Medical Research Organization Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 25. Global Heart Failure Therapeutics Market Size Share by Application: 2022 & 2029
    Figure 26. North America Heart Failure Therapeutics Revenue Market Share by Application (2018-2029)
    Figure 27. Europe Heart Failure Therapeutics Revenue Market Share by Application (2018-2029)
    Figure 28. Asia-Pacific Heart Failure Therapeutics Revenue Market Share by Application (2018-2029)
    Figure 29. Latin America Heart Failure Therapeutics Revenue Market Share by Application (2018-2029)
    Figure 30. Middle East and Africa Heart Failure Therapeutics Revenue Market Share by Application (2018-2029)
    Figure 31. Heart Failure Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 32. Global Top 5 and Top 10 Players Heart Failure Therapeutics Market Share in 2022
    Figure 33. North America Heart Failure Therapeutics Market Share by Country (2018-2029)
    Figure 34. U.S. Heart Failure Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 35. Canada Heart Failure Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 36. Germany Heart Failure Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 37. France Heart Failure Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 38. U.K. Heart Failure Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 39. Italy Heart Failure Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 40. Russia Heart Failure Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 41. Nordic Countries Heart Failure Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 42. Asia-Pacific Heart Failure Therapeutics Market Share by Region (2018-2029)
    Figure 43. China Heart Failure Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 44. Japan Heart Failure Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 45. South Korea Heart Failure Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 46. Southeast Asia Heart Failure Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 47. India Heart Failure Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 48. Australia Heart Failure Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 49. Latin America Heart Failure Therapeutics Market Share by Country (2018-2029)
    Figure 50. Mexico Heart Failure Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 51. Brazil Heart Failure Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 52. Middle East & Africa Heart Failure Therapeutics Market Share by Country (2018-2029)
    Figure 53. Turkey Heart Failure Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 54. Saudi Arabia Heart Failure Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 55. UAE Heart Failure Therapeutics Market Size (2018-2029) & (US$ Million)
    Figure 56. Bottom-up and Top-down Approaches for This Report
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3350

This license allows only one user to access the PDF.
Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS